192 related articles for article (PubMed ID: 9608408)
1. Delusional misidentification in association with parkinsonism.
Roane DM; Rogers JD; Robinson JH; Feinberg TE
J Neuropsychiatry Clin Neurosci; 1998; 10(2):194-8. PubMed ID: 9608408
[TBL] [Abstract][Full Text] [Related]
2. Capgras delusion for animals and inanimate objects in Parkinson's Disease: a case report.
Islam L; Piacentini S; Soliveri P; Scarone S; Gambini O
BMC Psychiatry; 2015 Apr; 15():73. PubMed ID: 25886646
[TBL] [Abstract][Full Text] [Related]
3. Delusional misidentification in Parkinson's disease: report of two cases and a review.
Hermanowicz N
Postgrad Med; 2018 Mar; 130(2):280-283. PubMed ID: 29185820
[TBL] [Abstract][Full Text] [Related]
4. Combined delusional misidentification syndrome in a patient with Parkinson's disease.
Cercy SP; Marasia JC
J Neuropsychiatry Clin Neurosci; 2012; 24(1):E3-4. PubMed ID: 22450637
[No Abstract] [Full Text] [Related]
5. Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease.
Moro A; Munhoz RP; Moscovich M; Arruda WO; Teive HA
Parkinsonism Relat Disord; 2013 Aug; 19(8):751-4. PubMed ID: 23680417
[TBL] [Abstract][Full Text] [Related]
6. Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease.
Ricciardi L; Espay KJ; Krikorian R; Fasano A; Espay AJ
Parkinsonism Relat Disord; 2016 Jul; 28():152-4. PubMed ID: 27086263
[No Abstract] [Full Text] [Related]
7. Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.
Zoldan J; Friedberg G; Weizman A; Melamed E
Adv Neurol; 1996; 69():541-4. PubMed ID: 8615178
[No Abstract] [Full Text] [Related]
8. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Meco G; Bernardi S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
[TBL] [Abstract][Full Text] [Related]
9. Delusional infestation induced by piribedil add-on in Parkinson's disease.
Kölle M; Lepping P; Kassubek J; Schönfeldt-Lecuona C; Freudenmann RW
Pharmacopsychiatry; 2010 Aug; 43(6):240-2. PubMed ID: 20614418
[No Abstract] [Full Text] [Related]
10. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
Merims D; Balas M; Peretz C; Shabtai H; Giladi N
Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
[TBL] [Abstract][Full Text] [Related]
11. When a Parkinson's disease patient starts to hallucinate.
Poewe W
Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
[TBL] [Abstract][Full Text] [Related]
12. Othello syndrome in Parkinson disease patients without dementia.
Cannas A; Solla P; Floris G; Tacconi P; Marrosu F; Marrosu MG
Neurologist; 2009 Jan; 15(1):34-6. PubMed ID: 19131855
[TBL] [Abstract][Full Text] [Related]
13. Fregoli syndrome: a rare persecutory delusion in a 17 year old sufferer of psychosis associated with typhoid fever at Jos University Teaching Hospital, Jos, Nigeria.
Stanley PC; Andrew AE
Niger J Med; 2002; 11(1):33-4. PubMed ID: 12073299
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
[TBL] [Abstract][Full Text] [Related]
15. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F
Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia.
Pagonabarraga J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
Mov Disord; 2008 Feb; 23(3):443-8. PubMed ID: 18076112
[TBL] [Abstract][Full Text] [Related]
17. Capgras syndrome in Parkinson's disease: two new cases and literature review.
Cannas A; Meloni M; Mascia MM; Solla P; Cocco L; Muroni A; Floris G; Di Stefano F; Marrosu F
Neurol Sci; 2017 Feb; 38(2):225-231. PubMed ID: 27848117
[TBL] [Abstract][Full Text] [Related]
18. Delusional misidentification syndromes in obsessive-compulsive disorder.
Melca IA; Rodrigues CL; Serra-Pinheiro MA; Pantelis C; Velakoulis D; Mendlowicz MV; Fontenelle LF
Psychiatr Q; 2013 Jun; 84(2):175-81. PubMed ID: 22922811
[TBL] [Abstract][Full Text] [Related]
19. A blind man with Parkinson's disease, visual hallucinations, and Capgras syndrome.
Hermanowicz N
J Neuropsychiatry Clin Neurosci; 2002; 14(4):462-3. PubMed ID: 12426417
[No Abstract] [Full Text] [Related]
20. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
